Schedule 13G ownership disclosure

Climb Bio, Inc.

Common Stock · CUSIP: 28658R106

Event date: 2026-10-27

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Deerfield Mgmt, L.P.

    Shares: 3,070,000.00 · Class: 5.25%

  • Deerfield Management Company, L.P.

    Shares: 3,070,000.00 · Class: 5.25%

  • Deerfield Partners, L.P.

    Shares: 3,070,000.00 · Class: 5.25%

  • James E. Flynn

    Shares: 3,070,000.00 · Class: 5.25%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193805-26-001408
Form type
SCHEDULE 13G
Filer
Climb Bio, Inc.
CIK
CIK 1768446
Filed
Oct 28, 2026
Reporting period
Oct 27, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub